News
VAXX
0.1326
-33.70%
-0.0674
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated fell 9.3% to $369.16 on Wednesday. The company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS guidance. Chicken Soup for the Soul Entertainment, Inc. Shares jumped 136% in the mid-day session.
Benzinga · 19h ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 27.8% to $0.58 during Wednesday's regular session. The company's market cap stands at $4.4 million. Prenetics Global and Alterity Therapeutics also moved upwards.
Benzinga · 20h ago
Why Vaxxinity (VAXX) Shares Are Volatile Today
Vaxxinity Inc (NASDAQ:VAXX) shares are trading lower by 10% to $0.24 on Tuesday. The company announced its intention to delist and deregister its Class A common stock from Nasdaq. The stock is trading lower on continued volatility after the company announced the move.
Benzinga · 1d ago
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
U.S. Stocks traded higher toward the end of trading on Monday. The Dow traded up 1.02% and the S&P 500 gained more than 1%. Financial shares climbed by 1.3% on Monday after Zions Bancorporation reported upbeat earnings. Moolec Science SA shares shot up 63% after receiving USDA approval for plant-grown animal proteins.
Benzinga · 2d ago
Why Vaxxinity (VAXX) Shares Are Down Nearly 50%
Vaxxinity Inc (NASDAQ:VAXX) shares are trading lower by 47% to $0.25. The company announced its intention to voluntarily delist and deregister its Class A common stock. The decision follows non-compliance with Nasdaq's minimum bid price requirement.
Benzinga · 2d ago
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's mid-day session. The company announced its intention to voluntarily delist and deregister its Class A common stock. Matterport, Inc., shares jumped 184% to $4.93.
Benzinga · 2d ago
12 Health Care Stocks Moving In Monday's Intraday Session
NKGen Biotech (NASDAQ:NKGN) shares rose 33.8% to $1.48 during Monday's regular session. The company's, Q4 earnings came out 4 days ago. MSP Recovery shares rose 29.74% and Assure Hldgs stock increased by 24.31%. Losers include Vaxxinity, Ocean Biomedical and Telomir Pharmaceuticals.
Benzinga · 2d ago
Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts
Nike layoffs will result in 740 employees at the company’s Beaverton, Ore., headquarters losing their jobs. This comes after the company announced plans to reduce its workforce by 2% in February. The company is planning to cut 1,600 jobs at its headquarters as part of a restructuring effort. Nike stock is down slightly on Monday morning after announcing the latest round of layoffs. Tesla, Hepion Pharmaceuticals and Vaxxinity are also in the news today.
Investorplace · 2d ago
Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March
U.S. Stocks traded higher on Monday, with the Dow Jones gaining over 100 points. The Dow traded up 0.31% to 38,104.99 while the NASDAQ rose 0.62%. The Chicago Fed National Activity Index increased to +0.15 in March. Information technology shares climbed by 0.8% on Monday. Asian markets closed mostly higher in Asia Pacific markets.
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Verizon, Tesla, Vista Outdoor
U.S. Stocks poised to open higher on Monday. Easing Middle East tensions buoyed risk appetite. Dow e-minis up 0.56% at 38,421.75. Top three NYSE percentage gainers: Brunswick Corp, KB Financial, Vista Outdoor. Tesla down 4.3% premarket.
Reuters · 2d ago
Health Care Sector Update for 04/22/2024: KURA, VAXX, MRNA, XLV, IBB
NASDAQ · 3d ago
Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
Hepion Pharmaceuticals is winding down its Phase 2b NASH study. The study couldn't reach the planned 336 patients and only got to 151. With this news comes a 40.5% drop for HEPA stock on Monday morning. Vaxxinity stock, OLB Group stock and Moolec Science stock also fell today.
Investorplace · 3d ago
Why Is Vaxxinity (VAXX) Stock Down 58% Today?
Vaxxinity (NASDAQ:VAXX) stock is down 58% on Monday after the biotechnology company announced plans to voluntarily delist its shares from the Nasdaq Exchange. The company expects its final day of trading to be May 9, 2024. VAXX stock is expected to trade on the OTC Markets after May 9. We have all of the hottest stock market stories that traders need to know about on Monday.
Investorplace · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Adial Pharmaceuticals (NASDAQ:ADIL) stock rose 34.2% to $2.59 during Monday's pre-market session. NKGen Biotech and T2 Biosystems moved upwards. Vaxxinity stock declined by 61.3% during the session.
Benzinga · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-EV stocks, Salesforce, Verizon
U.S. Stock index futures gain on Monday after slumping in the previous session. Easing Middle East tensions buoyed risk sentiment. Investors look ahead to major tech earnings and a key inflation print this week. Tesla shares fall after the company cuts prices. Salesforce up 3.4% in premarket.
Reuters · 3d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Moolec Science stock is rocketing more than 67% on approval for its plant-groan animal proteins. Vaxxinity stock is crashing more than 55% on the company's plans to delist its shares. The biggest pre-market stock movers for Monday morning are earnings, investments, a delisting and more.
Investorplace · 3d ago
Weekly Report: what happened at VAXX last week (0415-0419)?
Weekly Report · 3d ago
Why Riot Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Riot Platforms, Inc. Rose sharply in today's pre-market trading. Bitcoin prices gained around 1.5% over the past 24 hours to $66,012 this morning. The company's shares rose 5.3% to $9.61 in pre- market trading.
Benzinga · 3d ago
More
Webull provides a variety of real-time VAXX stock news. You can receive the latest news about Vaxxinity, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About VAXX
Vaxxinity, Inc. is a biotechnology company. The Company is engaged in the development of rationally designed prophylactic and therapeutic vaccines to combat common chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its synthetic peptide-based Active Immunotherapy Medicines Platform (AIM Platform, formerly called the Vaxxine Platform) has the potential to enable a new class of medicines. Its pipeline consists of five lead programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications. Its pipeline includes UB-311, UB-312, VXX-301, VXX-401 and UB-313. It also has developed an infectious disease product candidate, UB-612, as a heterologous booster against COVID-19. Its UB-311, which targets the primary pathological process of Alzheimer’s disease (AD) and UB-312, which targets the pathological process of Parkinson’s disease (PD) and other so-called synucleinopathies.